The store will not work correctly when cookies are disabled.
N-(3,4-dichlorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide
ID: ALA4868945
PubChem CID: 17715324
Max Phase: Preclinical
Molecular Formula: C16H10Cl2N2O2
Molecular Weight: 333.17
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(Nc1ccc(Cl)c(Cl)c1)c1c[nH]c2ccccc2c1=O
Standard InChI: InChI=1S/C16H10Cl2N2O2/c17-12-6-5-9(7-13(12)18)20-16(22)11-8-19-14-4-2-1-3-10(14)15(11)21/h1-8H,(H,19,21)(H,20,22)
Standard InChI Key: ZLSLNYMMJKNCEM-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
19.9042 -1.9067 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.9031 -2.7263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6111 -3.1352 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.6093 -1.4979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3179 -1.9031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.3187 -2.7222 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0272 -3.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7355 -2.7184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.7308 -1.8963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0217 -1.4929 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.0289 -3.9464 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
23.4448 -3.1242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.4480 -3.9414 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
24.1509 -2.7129 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
24.8602 -3.1187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8587 -3.9343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5672 -4.3401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2743 -3.9287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.2684 -3.1073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.5594 -2.7052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.9841 -4.3336 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
26.9731 -2.6935 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 5 1 0
7 11 2 0
8 12 1 0
12 13 2 0
12 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
18 21 1 0
19 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 333.17 | Molecular Weight (Monoisotopic): 332.0119 | AlogP: 4.09 | #Rotatable Bonds: 2 |
Polar Surface Area: 61.96 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 10.57 | CX Basic pKa: ┄ | CX LogP: 4.18 | CX LogD: 4.18 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.74 | Np Likeness Score: -1.34 |
References
1. Mesiti F, Maruca A, Silva V, Rocca R, Fernandes C, Remião F, Uriarte E, Alcaro S, Gaspar A, Borges F.. (2021) 4-Oxoquinolines and monoamine oxidase: When tautomerism matters., 213 [PMID:33493825] [10.1016/j.ejmech.2021.113183] |